STO Equity Snapshot
GUARD Weekly Equity Report
Guard Therapeutics International AB (publ)
What the company does
Guard Therapeutics International AB (publ), a clinical-stage biotechnology company, identifies and develops medicines to treat kidney diseases in Sweden. The company's pipeline products include RMC-035, an intact therapeutic A1M protein, that is in Phase 2b clinical trial for kidney protection with open-heart surgery; in Phase 2a clinical trial for kidney transplantation; and is in preclinical trial to treat Sepsis. It also develops GTZ peptides, a modified A1M-derived peptides which is in preclinical studies for the treatment of CKD and diabetes, heart failure, alport syndrome, sickle-cell nephropathy, and preeclampsia. The company was formerly known as A1M …
What the weekly tape is saying
GUARD closed the latest completed week at 1.59 SEK. The 4-week return is 9.8% and the 12-week return is 2.3%. Trend Signal is inactive, Market Dynamics is 0.76. Setup signature: Deep recovery attempt with a 45/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 1.48 SEK
- Vs Trend Line
- 7.1%
- Fair Value
- 18.26 SEK
- Vs Fair Value
- -91.3%
- 52W High
- 27.00 SEK
- 52W Low
- 0.88 SEK
- Drawdown
- -94.1%
- Range Position
- 2.7%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 9
- 52W Active Breadth
- 17.3%
- Sector Scope
- SE Healthcare
- Sector Rank
- 11 of 158
- Sector Percentile
- 93.6%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
SE Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 2.8%
- Avg 4W
- 1.2%
- Trend Breadth
- 29.0%
- Positive MD
- 69.0%
SE Biotechnology
- Tracked Peers
- 59
- 4W Rank
- 10 of 59
- Avg 1W
- 3.1%
- Avg 4W
- -1.6%
- Trend Breadth
- 30.5%
- Positive RS
- 22.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.76
- 4W MD Change
- 241.6%
- Relative Strength
- -84.22
- 4W RS Change
- 3.5%
- Expectation
- Undecided
- Probability
- 47.14%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 818.4K
- 13W Average
- 219.4K
- 52W Average
- 418.1K
- Vs 13W
- 3.7x
- Vs 52W
- 2.0x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 11.7%
- 52W Volatility
- 16.8%
- Upside Weeks
- 25
- Downside Weeks
- 25
- Downside Breadth
- 48.1%
- Avg Gain / Loss
- 8.9% / -10.4%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- STO
- Country
- SE
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- SEK
- Market Cap
- 28.9M
Opportunity signals
- Price is above the Trend Line, keeping the weekly tape constructive.
- Market Dynamics is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 1.59 SEK | 13.6% | 1.48 SEK | 18.26 SEK | 0.76 | -84.22 | 818.4K | Off |
| 5 Jun 2026 | 1.40 SEK | -2.4% | 1.48 SEK | 18.29 SEK | 0.67 | -86.65 | 17.0K | Off |
| 29 May 2026 | 1.43 SEK | 7.2% | 1.48 SEK | 18.32 SEK | 0.61 | -86.94 | 98.1K | Off |
| 22 May 2026 | 1.34 SEK | -7.6% | 1.49 SEK | 18.34 SEK | 0.39 | -88.28 | 78.1K | Off |
| 15 May 2026 | 1.45 SEK | 21.9% | 2.21 SEK | 18.37 SEK | 0.22 | -87.27 | 333.8K | Off |
| 8 May 2026 | 1.19 SEK | 12.1% | 2.92 SEK | 18.40 SEK | 0.04 | -89.97 | 289.8K | Off |
| 1 May 2026 | 1.06 SEK | 10.0% | 3.62 SEK | 18.43 SEK | -0.01 | -91.24 | 88.3K | Off |
| 24 Apr 2026 | 0.96 SEK | -23.0% | 4.23 SEK | 18.47 SEK | 0.12 | -92.33 | 455.4K | Off |
| 17 Apr 2026 | 1.25 SEK | 4.3% | 4.96 SEK | 18.50 SEK | 0.24 | -90.53 | 175.0K | Off |
| 10 Apr 2026 | 1.20 SEK | -11.8% | 5.69 SEK | 18.53 SEK | 0.25 | -90.92 | 165.9K | Off |
| 3 Apr 2026 | 1.36 SEK | -7.8% | 6.38 SEK | 18.57 SEK | 0.26 | -89.44 | 196.6K | Off |
| 27 Mar 2026 | 1.48 SEK | -5.1% | 7.10 SEK | 18.87 SEK | 0.23 | -88.45 | 99.8K | Off |
| 20 Mar 2026 | 1.55 SEK | 0.0% | 7.79 SEK | 19.22 SEK | 0.23 | -88.11 | 36.0K | Off |
| 13 Mar 2026 | 1.55 SEK | -2.8% | 8.48 SEK | 19.58 SEK | 0.26 | -88.96 | 87.6K | Off |